FDA·Healthcare and labs·October 28, 2026

Medtronic MiniMed recalls CareLink Clinic software version 4.4A over incorrect insulin setting calculations

The Settings Calculator in CareLink Clinic software version 4.4A does not use custom values entered by healthcare professionals, so it gives incorrect rapid-acting insulin settings and a patient could get higher or lower insulin doses than needed.

What to do

The notice does not give instructions. Read the official notice for details.

Recall details

Product
CareLink Clinic, REF: MMT-7350
Hazard
CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the…
Units
1
Where sold
US Nationwide distribution in the state of KS.
FDA classification
Class II · Ongoing
Classified by FDA
October 21, 2026
Recall started
September 11, 2026
FDA enforcement report
October 28, 2026
Identifiers
  • Codes: UDI-DI: 0763000B00008748K. Software Versions: 4.4A Software Available: US: Between June 4th, 2026, and June 8th, 2026.
  • FDA recall number: Z-0203-2027

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
CareLink Clinic, REF: MMT-7350
Reason for recall
CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the patient could deliver higher or lower insulin doses compared to their insulin needs, potentially leading to over/under delivery of insulin with a severity ranging from Catastrophic (death from severe hypoglycemia) to Minor (self-treatable hypoglycemia/hyperglycemia).
Classification
Class II (Ongoing)
Distribution
US Nationwide distribution in the state of KS.
Quantity
1

Related recalls